5 Reproductive Medicine Center, The First Hospital of Lanzhou University, Lanzhou, Gansu, China Gastric cancer, a prevalent malignancy globally, is influenced by various factors. The imbalance in the ...

The ACS estimates that the U.S. will see about 30,300 new cases of gastric cancer in 2025, and about 10,780 deaths from this type of cancer (6,400 men and 4,380 women).

Gastric cancer remains a major health challenge worldwide, with nearly 1 million new cases annually contributing to more than 650 000 deaths. Epidemiologically, gastric cancer shows substantial ...

Patients carrying at least one of the four key genes show a significantly increased risk for disease recurrence and mortality in gastric cancer, according to new research that potentially paves ...

The absolute number of annual cases of gastric cancer in Europe is rising. The Council of the European Union has recommended implementation of gastric cancer screening for countries or regions with a ...

The first-line combination of nivolumab (Opdivo) and chemotherapy continued to show deep responses and an overall survival (OS) benefit vs chemotherapy alone in patients with advanced gastric cancer, ...

Gastric cancer is the fifth most commonly diagnosed cancer and the fourth leading cause of cancer deaths worldwide (Sung et al, 2021). Approximately 40% of gastric cancer patients present with ...

Early detection is of great significance for improving prognosis of patients with gastric cancer (GC). Liquid biopsy is a revolutionary tool for early diagnosis and prognosis prediction of GC. In ...

Gastric cancer (GC) is one of the most common malignancies and a prominent cause of cancer mortality worldwide. A distinctive characteristic of GC is its intimate association with commensal microbial ...

Key Takeaways Stivarga improved survival in refractory advanced gastric and esophagogastric junction cancer, reducing the risk for death by 30% and a median survival of 4.5 months. The 12-month ...